AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35717385 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief counselling strategies
Number of subjects: 0
Study 33311789 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunderbeat™ device during the Whipple procedure
Number of subjects: 32
Study 33311789 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 32
Study 35181552 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Spatial Filtering (DSF)
Number of subjects: 4100
Study 35181552 — intervention group
Group type: COMPARATOR
Intervention: Baseline models
Number of subjects: 4100
Study 33381794 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose supplementation 3 times daily
Number of subjects: 44
Study 33381794 — intervention group
Group type: COMPARATOR
Intervention: Fructose supplementation 3 times daily
Number of subjects: 44
Study 33203954 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP4345 (3, 15, 50, and 150 mg; n = 9 each dose)
Number of subjects: 48
Study 33203954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33203954 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP4345
Number of subjects: 48
Study 33345794 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized low-glycemic index diet (n=139 women; 1800 kcal/d + 30 minutes walking 4 times/wk)
Number of subjects: 273
Study 33345794 — intervention group
Group type: COMPARATOR
Intervention: Standard care (generic lifestyle advice; n=134 women)
Number of subjects: 273
Study 36368259 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing + support services
Number of subjects: 240
Study 36368259 — intervention group
Group type: COMPARATOR
Intervention: Housing-only
Number of subjects: 240
Study 36368259 — intervention group
Group type: COMPARATOR
Intervention: Services as usual (SAU)
Number of subjects: 240
Study 33317824 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (PT) devices provided to hospitals
Number of subjects: 0
Study 33317824 — intervention group
Group type: COMPARATOR
Intervention: Standard PT (irradiance < 30 µW/cm2/nm)
Number of subjects: 0
Study 33317824 — intervention group
Group type: COMPARATOR
Intervention: Sunlight treatment
Number of subjects: 0
Study 33935152 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital therapy group (12-week home-based digitally assisted rehabilitation program with 13 face-to-face sessions)
Number of subjects: 50
Study 33935152 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy group (30 sessions of conventional face-to-face physical therapy)
Number of subjects: 50
Study 35586820 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming Yang, tonifying kidney, and removing arthralgia therapy
Number of subjects: 72
Study 35586820 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment not specified)
Number of subjects: 72
Study 33272036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 26
Study 33272036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 35668532 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week multimodal, individualized prehabilitation program including exercise therapy, nutritional intervention, mobility or balance training, and psychosocial interventions and medical assessment, supervised 5 times/week for 3 weeks.
Number of subjects: 1400
Study 35668532 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making process with the patient, relatives, and an interdisciplinary and interprofessional team.
Number of subjects: 1400
Study 32846841 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional barbed suture (Stratafix1-0 for joint capsule, Stratafix2-0 for subcutaneous, Stratafix3-0 for intracutaneous)
Number of subjects: 100
Study 32846841 — intervention group
Group type: COMPARATOR
Intervention: Traditional absorbable suture (Ethicon VICRYL* Plus 1-0 for joint capsule, Ethicon VICRYL* Plus 2-0 for subcutaneous, staples for skin)
Number of subjects: 100
Study 36138517 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab + TPE + IST
Number of subjects: 104
Study 36138517 — intervention group
Group type: COMPARATOR
Intervention: Placebo + TPE + IST
Number of subjects: 104
Study 36138517 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab for recurrence
Number of subjects: 104
Study 36138517 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab for second recurrences
Number of subjects: 104
Study 36138517 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 104
Study 34282568 — intervention group
Group type: EXPERIMENTAL
Intervention: S. salivarius BLIS K12
Number of subjects: 0
Study 34282568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35754090 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding Hands Young Parents (HHYP) intervention
Number of subjects: 4
Study 34488799 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-parametric Multivariate Random Forest (MM-RF) model
Number of subjects: 116
Study 34488799 — intervention group
Group type: COMPARATOR
Intervention: Clinical visual analysis
Number of subjects: 116
Study 33011010 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-level obesity-targeted intervention
Number of subjects: 280
Study 33011010 — intervention group
Group type: COMPARATOR
Intervention: Referral to community services (control)
Number of subjects: 280
Study 34664106 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF-6 (6 mg/kg caffeine)
Number of subjects: 12
Study 34664106 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF-3 (3 mg/kg caffeine)
Number of subjects: 12
Study 34664106 — intervention group
Group type: COMPARATOR
Intervention: CON (no supplementation)
Number of subjects: 12
Study 34664106 — intervention group
Group type: COMPARATOR
Intervention: PLAC (placebo)
Number of subjects: 12
Study 34662382 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 1064
Study 34662382 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 1064
Study 32589244 — intervention group
Group type: COMPARATOR
Intervention: Analgesic treatment only (Group A)
Number of subjects: 114
Study 32589244 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy and analgesic treatment (Group B)
Number of subjects: 114
Study 33734529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot or feasibility study consent process
Number of subjects: 0
Study 33734529 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic misconception and therapeutic misestimation
Number of subjects: 0
Study 33734529 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication in consent process
Number of subjects: 0
Study 33068791 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a prescribed dose of 35 Gy in five fractions
Number of subjects: 38
Study 33068791 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 38
Study 34167891 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz left/bilateral)
Number of subjects: 30
Study 34167891 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 34030726 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir in hair
Number of subjects: 0
Study 34030726 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir in hair with adequate adherence, normal BMI-for-age, and mature guardians
Number of subjects: 0
Study 32415664 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 162
Study 32415664 — intervention group
Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 162
Study 34414801 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Charge intervention (one or two sessions)
Number of subjects: 400
Study 34414801 — intervention group
Group type: COMPARATOR
Intervention: Control (no Take Charge sessions)
Number of subjects: 400
Study 33413311 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron therapy (4 weeks before surgery)
Number of subjects: 64
Study 33413311 — intervention group
Group type: COMPARATOR
Intervention: Autologous whole blood therapy (2 units collected 4 and 2 weeks before surgery)
Number of subjects: 64
Study 33413311 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron therapy
Number of subjects: 64
Study 33413311 — intervention group
Group type: COMPARATOR
Intervention: Autologous whole blood therapy
Number of subjects: 64
Study 33194963 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide-based intensive glucose control (IGC)
Number of subjects: 11140
Study 33194963 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose control (SGC)
Number of subjects: 11140
Study 36058135 — intervention group
Group type: EXPERIMENTAL
Intervention: Food response inhibition and attention training
Number of subjects: 179
Study 36058135 — intervention group
Group type: COMPARATOR
Intervention: Placebo control training protocol with non-food images
Number of subjects: 179
Study 36000037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intranasal desmopressin (40 μg)
Number of subjects: 120
Study 36000037 — intervention group
Group type: COMPARATOR
Intervention: Low-dose intranasal desmopressin (20 μg)
Number of subjects: 120
Study 36000037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32380428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 32380428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33156447 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI treatment
Number of subjects: 79
Study 35321754 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (theatre workshop + self-management workshops)
Number of subjects: 358
Study 35321754 — intervention group
Group type: COMPARATOR
Intervention: Theatre only
Number of subjects: 358
Study 35321754 — intervention group
Group type: COMPARATOR
Intervention: Usual care (controls)
Number of subjects: 358
Study 33394523 — intervention group
Group type: EXPERIMENTAL
Intervention: Early e-cigarette users (at 13-14 years)
Number of subjects: 3289
Study 33394523 — intervention group
Group type: EXPERIMENTAL
Intervention: Late e-cigarette users (at 14-15 years)
Number of subjects: 3289
Study 35820631 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin administration at physiological replacement doses during fasting (study 1)
Number of subjects: 37
Study 35820631 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin administration at supraphysiological and pharmacological doses during fasting (study 2)
Number of subjects: 37
Study 35820631 — intervention group
Group type: COMPARATOR
Intervention: Leptin treatment for two months in hypoleptinemic men with HIV (study 3)
Number of subjects: 37
Study 35820631 — intervention group
Group type: COMPARATOR
Intervention: Placebo during fasting (study 1)
Number of subjects: 37
Study 33142037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinbaglustat (10 to 2000 mg single doses; 30 to 1000 mg twice daily for 7 days)
Number of subjects: 0
Study 33142037 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 35723814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruyi Zhenbao Pills (RZPs) for 4 weeks
Number of subjects: 120
Study 35723814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34078362 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Away Plus (WAP)
Number of subjects: 1366
Study 34078362 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Away (WA)
Number of subjects: 1366
Study 34078362 — intervention group
Group type: COMPARATOR
Intervention: Control (information leaflet)
Number of subjects: 1366
Study 32245522 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually randomized controlled trials (RCTs)
Number of subjects: 200
Study 32245522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized controlled trials (CRTs)
Number of subjects: 200
Study 35867804 — intervention group
Group type: EXPERIMENTAL
Intervention: istaroxime 1.0‐1.5 μg/kg/min
Number of subjects: 60
Study 32898271 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant HA vaccine (rHA)
Number of subjects: 133
Study 32898271 — intervention group
Group type: COMPARATOR
Intervention: Egg-derived inactivated influenza vaccine (IIV)
Number of subjects: 133
Study 32898271 — intervention group
Group type: COMPARATOR
Intervention: Cell-derived inactivated influenza vaccine (IIV)
Number of subjects: 133
Study 32898271 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 133
Study 35913888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutures alone
Number of subjects: 295
Study 35913888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutures and adhesive tape
Number of subjects: 295
Study 35913888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutures and tissue adhesive
Number of subjects: 295
Study 35913888 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 295
Study 33991711 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF injections (as-needed regimen)
Number of subjects: 393
Study 33176394 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy (RT), 26 sessions, twice a week for 13 weeks
Number of subjects: 251
Study 33176394 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 251
Study 33933742 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised nutritional support
Number of subjects: 1943
Study 33933742 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital food
Number of subjects: 1943
Study 36347152 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention in addition to conventional physiotherapy and CPM equipment
Number of subjects: 55
Study 36347152 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy and CPM equipment (Control group)
Number of subjects: 55
Study 36347152 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (including VR and Control)
Number of subjects: 55
Study 32522066 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined Deep Seawater (RDSW) for 8 weeks
Number of subjects: 78
Study 32522066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 33745859 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular Surgery (VS) Letters
Number of subjects: 198
Study 33745859 — intervention group
Group type: COMPARATOR
Intervention: Ob/Gyn Letters
Number of subjects: 198
Study 34358954 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 300 mg glycerol monolaurate/kg
Number of subjects: 180
Study 34358954 — intervention group
Group type: COMPARATOR
Intervention: Corn-soybean meal based diet
Number of subjects: 180
Study 33273441 — intervention group
Group type: EXPERIMENTAL
Intervention: Good muscle health grade 'A' (GC≤2 and PL-CSA/BMI≥130)
Number of subjects: 308
Study 34840945 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Yoga intervention administered via e-Yoga modalities
Number of subjects: 135
Study 33373666 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 220
Study 33373666 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-moderate exercise
Number of subjects: 220
Study 33373666 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 36320174 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 24 mg every 12 h for 90 days
Number of subjects: 62
Study 36320174 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets every 12 h for 90 days
Number of subjects: 62
Study 36320174 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine
Number of subjects: 62
Study 36320174 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine and Control
Number of subjects: 62
Study 33078561 — intervention group
Group type: EXPERIMENTAL
Intervention: M-CHAT/F screening for ASD
Number of subjects: 3343
Study 33078561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital diagnosis process initiation
Number of subjects: 3343
Study 33078561 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-to-follow-up during hospital diagnosis process
Number of subjects: 3343
Study 32517521 — intervention group
Group type: EXPERIMENTAL
Intervention: Chores, errands, and work (for girls)
Number of subjects: 395
Study 32517521 — intervention group
Group type: EXPERIMENTAL
Intervention: Play (for boys)
Number of subjects: 395
Study 32517521 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 395
Study 32517521 — intervention group
Group type: EXPERIMENTAL
Intervention: Chores, errands, and work (public vs private school girls)
Number of subjects: 395
Study 34111588 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to positivity (TTP) for Candida spp.
Number of subjects: 3462
Study 34111588 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to positivity (TTP) for streptococci.
Number of subjects: 3462
Study 34111588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever
Number of subjects: 3462
Study 34111588 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3462
Study 34111588 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophilia
Number of subjects: 3462
Study 34098667 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD+periodontitis group
Number of subjects: 138
Study 34098667 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontitis group
Number of subjects: 138
Study 36118838 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nursing based on MDT concept
Number of subjects: 110
Study 36118838 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 110
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at sea level
Number of subjects: 8
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at sea level
Number of subjects: 8
Study 32736909 — intervention group
Group type: COMPARATOR
Intervention: No Singing (NS) at sea level
Number of subjects: 8
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at 3000 m
Number of subjects: 8
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at 3000 m
Number of subjects: 8
Study 32736909 — intervention group
Group type: COMPARATOR
Intervention: No Singing (NS) at 3000 m
Number of subjects: 8
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at 5000 m
Number of subjects: 8
Study 32736909 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at 5000 m
Number of subjects: 8
Study 32736909 — intervention group
Group type: COMPARATOR
Intervention: No Singing (NS) at 5000 m
Number of subjects: 8
Study 35738869 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed and directed physical exercise (PDPE)
Number of subjects: 64
Study 35738869 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 33854039 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1500 mg/day
Number of subjects: 30
Study 33854039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32120198 — intervention group
Group type: EXPERIMENTAL
Intervention: eCHECKUPTOGO-marijuana (BI)
Number of subjects: 49
Study 32120198 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CTL)
Number of subjects: 49
Study 36153858 — intervention group
Group type: EXPERIMENTAL
Intervention: DW1601
Number of subjects: 204
Study 36153858 — intervention group
Group type: COMPARATOR
Intervention: DW16011
Number of subjects: 204
Study 36153858 — intervention group
Group type: COMPARATOR
Intervention: P. sidoides
Number of subjects: 204
Study 34040690 — intervention group
Group type: EXPERIMENTAL
Intervention: Only sealer (S)
Number of subjects: 80
Study 34040690 — intervention group
Group type: COMPARATOR
Intervention: Single-cone technique with gutta-percha (GP-S)
Number of subjects: 80
Study 34040690 — intervention group
Group type: EXPERIMENTAL
Intervention: BioRoot™ RCS
Number of subjects: 80
Study 34040690 — intervention group
Group type: COMPARATOR
Intervention: EndoSequence® BC Sealer™
Number of subjects: 80
Study 34040690 — intervention group
Group type: EXPERIMENTAL
Intervention: Powder-liquid bioceramic sealers (BioRoot™ RCS and ProRoot® ES)
Number of subjects: 80
Study 34040690 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot® ES
Number of subjects: 80
Study 34040690 — intervention group
Group type: COMPARATOR
Intervention: Premixed sealer (EndoSequence® BC Sealer™)
Number of subjects: 80
Study 34923177 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast in the Classroom (BIC) initiative
Number of subjects: 1362
Study 34923177 — intervention group
Group type: COMPARATOR
Intervention: Control (breakfast served in the cafeteria before school)
Number of subjects: 1362
Study 35717595 — intervention group
Group type: EXPERIMENTAL
Intervention: ECHO (carer skills intervention) added to treatment as usual (TAU)
Number of subjects: 149
Study 35717595 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 149
Study 33597136 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt consumption
Number of subjects: 1856
Study 33597136 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity (daily walking)
Number of subjects: 1856
Study 33597136 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt + Physical Activity
Number of subjects: 1856
Study 33597136 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 1856
Study 33597136 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (Yoghurt, PA, Yoghurt + PA)
Number of subjects: 1856
Study 32943858 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary home rehabilitation for a maximum of 10 weeks
Number of subjects: 205
Study 32943858 — intervention group
Group type: COMPARATOR
Intervention: In-hospital geriatric care
Number of subjects: 205
Study 32943858 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary home rehabilitation
Number of subjects: 205
Study 32943858 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia
Number of subjects: 205
Study 35363874 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarettes for 8 weeks
Number of subjects: 240
Study 35363874 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only group
Number of subjects: 240